Founded in April 2016 and headquartered in Shenzhen, DeepSnow Capital has been committed to providing professional and customized capital market financial advisory services for high-quality start-ups in the booming health industry with a strong angle for China , including but not limited to equity financing, mergers and acquisitions, asset restructuring, product licensing, and business development.

 

Our clients operate in all major sub-sectors, including Biotech, medical device, healthcare service and digital health, ranging from early to growth stage.

 

We are familiar with the common practice of domestic and international capital markets, good at unlocking the potential of target clients, and well-connected in the vast network of professional healthcare investors. We are proud of having navigated dozens of our clients through a variety of important but challenging transactions over the past 8 years, with total transaction value about 1 billion USD. We have an in-depth knowledge about the needs and styles of those major healthcare investment institutions. Our approach is to adapt the world-class investment bank techniques and experiences from Wall Street powerhouses to address the practical and painful issues of millions of start-ups in the broad healthcare industry especially in China. Leveraging the power of capital markets, we help our clients grow healthily and rapidly, aiming to create a healthy world altogether.